Hepatic Drug Interaction Between Tacrolimus and Lansoprazole in a Bone Marrow Transplant Patient Receiving Voriconazole and Harboring CYP2C19 and CYP3A5 Heterozygous Mutations

Hepatic Drug Interaction Between Tacrolimus and Lansoprazole in a Bone Marrow Transplant Patient Receiving Voriconazole and Harboring CYP2C19 and CYP3A5 Heterozygous Mutations
复制标题

接受伏立康唑且携带 CYP2C19 和 CYP3A5 杂合突变的骨髓移植患者中他克莫司和兰索拉唑之间的肝脏药物相互作用

DOI:
--
复制
发表时间:
2011
期刊:
影响因子:
3.2
通讯作者:
Okuda M
Okuda M
中科院分区:
医学3区
文献类型:
--
作者:
Iwamoto T;Monma F;Fujieda A;Nakatani K;Katayama N;Okuda M

文献摘要

相似文献